Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Crenezumab

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Genentech tries again on diversity aim for Alzheimer's program
    Genentech tries again on diversity aim for Alzheimer's program

    08 Aug 2022

    // Annalee Armstrong FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/genentech-didnt-get-it-right-diversity-critical-graduate-alzheimers-program-theyre-trying

    Annalee Armstrong FIERCEBIOTECH
    08 Aug 2022
    Share Share
    Genentech, AC Immune reveal more about crenezumab failure
    Genentech, AC Immune reveal more about crenezumab failure

    02 Aug 2022

    // Annalee Armstrong FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/genentech-ac-immune-crenezumab-failed-trial-alzheimers-aaic-conference-ceo-pfiefer

    Annalee Armstrong FIERCEBIOTECH
    02 Aug 2022
    Share Share
    NextGen: Alzheimer's therapy developers find reason for optimism
    NextGen: Alzheimer's therapy developers find reason for optimism

    29 Jun 2022

    // Annalee Armstrong FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/fierce-nextgen-despite-another-key-trial-failure-alzheimers-therapy-developers-find-reason

    Annalee Armstrong FIERCEBIOTECH
    29 Jun 2022
    Share Share
    Another amyloid miss in Alzheimer’s as Roche’s crenezumab fails trial
    Another amyloid miss in Alzheimer’s as Roche’s crenezumab fails trial

    17 Jun 2022

    // Phil Taylor PHARMAPHORUM

    https://pharmaphorum.com/news/another-amyloid-miss-in-alzheimers-as-roches-crenezumab-fails-trial/

    Phil Taylor PHARMAPHORUM
    17 Jun 2022
    Share Share
    AC Immune Provides Update On Alzheimer’s Prevention Initiative Study Evaluating Crenezumab
    AC Immune Provides Update On Alzheimer’s Prevention Initiative Study Evaluating Crenezumab

    16 Jun 2022

    // PRESS RELEASE

    https://ir.acimmune.com/news-releases/news-release-details/ac-immune-provides-update-alzheimers-prevention-initiative-study

    PRESS RELEASE
    16 Jun 2022
    Share Share
    Shehnaaz Suliman dives back into Alzheimer's at Alector
    Shehnaaz Suliman dives back into Alzheimer's at Alector

    14 Dec 2019

    // Kathy Wong ENDPTS

    https://endpts.com/shehnaaz-suliman-dives-back-into-alzheimers-at-alector-pyxis-recruits-springworks-founder-lara-sullivan-as-ceo/

    Kathy Wong ENDPTS
    14 Dec 2019
    Share Share